The title of this article leads us to think that we will find a list of things that we can do to reduce kidney injury. However, (unfortunately) sodium bicarbonate showed no benefit over saline and n-acetylcysteine showed no benefit over a placebo for the reduction of kidney damage after coronary angioplasty. Among the protective measures<a href="https://solaci.org/en/2018/12/06/strategies-to-reduce-acute-kidney-injury-in-angioplasty/" title="Read more" >...</a>
The ASCEND and ARRIVE trials -presented at the European Cardiology Congress and published in The New England Journal of Medicine (NEJM) and The Lancet respectively- have put against the ropes the indication of aspirin in the context of primary prevention. The ASPREE trial, recently published in the NEJM, appears to have definitely overthrown aspirin, since<a href="https://solaci.org/en/2018/12/04/aspirin-bleeding-and-cardiovascular-events-in-healthy-elderly/" title="Read more" >...</a>
Sirolimus-eluting stents with biodegradable polymer did not offer better outcomes compared with instant-classic (and undoubtedly valid) everolimus-eluting stents with durable polymer such as Xience. New-generation drug-eluting stents (DES) offer better outcomes than first-generation devices after a 10-year follow-up, according to the ISAR-TEST 4 trial presented at the American Heart Association (AHA) Congress Scientific Sessions and published<a href="https://solaci.org/en/2018/11/30/aha-2018-new-generation-des-are-similar-to-second-generation-des-beyond-polymer/" title="Read more" >...</a>
The benefits offered to patients by attempting the rechanneling of a chronic total occlusion are still unclear. Additionally, sometimes the procedural risks are somewhat undetermined. Taking into account these controversies, this work sought to prove whether successful rechanneling of a chronic total occlusion improves ventricular function. This is not a soft endpoint; it has been<a href="https://solaci.org/en/2018/11/23/clinical-improvement-without-ventricular-function-improvement-after-cto/" title="Read more" >...</a>
Hopes were raised high by the ARTS study, when set to show the benefit of bilateral internal mammary arteries (BIMA) during coronary artery bypass graft surgery compared over the use of a single internal mammary artery (SIMA) at 10 year follow up, but only one sub-study was able to show an advantage over radial grafts.<a href="https://solaci.org/en/2018/11/07/myocardial-revascularization-surgery-hits-a-plateau/" title="Read more" >...</a>
Coronary perforation has an incidence of 0.5% and it is associated with a 13-fold increase in in-hospital events and a 5-fold increase in 30-day mortality. This event is so catastrophic that its management has become indispensable knowledge to all interventional cardiologists. This accident is most frequently provoked by artery over-dilation caused by a balloon or<a href="https://solaci.org/en/2018/11/06/practical-management-of-coronary-perforations/" title="Read more" >...</a>
There is limited information on the use of antithrombotic therapies and their outcomes in Latin American patients with atrial fibrillation. This stands true in almost all aspects of medicine: large multicenter randomized studies rarely include Latin American countries, and when they do, the population included is not representative of the overall population. The only exception<a href="https://solaci.org/en/2018/11/02/new-anticoagulant-agents-in-atrial-fibrillation-in-latin-american-patients-specifically/" title="Read more" >...</a>
Time to endovascular treatment after ischemic stroke is strongly associated to functional outcomes. This association could be even stronger than previously suggested in more select populations of controlled studies. These findings emphasize that functional outcomes after endovascular treatment could be improved significantly by reducing onset to treatment times. Randomized studies in select acute<a href="https://solaci.org/en/2018/10/23/mr-clean-registry-time-is-brain-is-a-far-more-accurate-than-time-is-heart/" title="Read more" >...</a>
The incidence of arrhythmic events up to a year after implantation is high and involves almost half the patients with complete left bundle branch block following the procedure. Significant bradyarrhythmias occur in up to one-fifth of the patients, half of whom ultimately require a pacemaker. These data support the idea of a cardiac monitoring device<a href="https://solaci.org/en/2018/10/18/ambulatory-continuous-monitoring-in-patients-with-left-bundle-branch-block-after-tavi/" title="Read more" >...</a>
This study shows the benefit of reducing waiting time between acute events and intervention in patients with severe symptomatic carotid stenosis. Its outcomes support the efforts to reduce patient management. Moreover, it could be used as an indicator of clinical practice quality. The risk of recurrent events after an ischemic event is significantly higher in<a href="https://solaci.org/en/2018/10/12/effect-of-more-expedited-carotid-intervention-on-recurrent-events/" title="Read more" >...</a>